Methylphenidate 8.6mg, 17.3mg, 25.9mg; ext-rel orally disintegrating tabs. High potential for abuse, misuse, and addiction; assess patient's risk before prescribing. Assess for presence of cardiac ...

Under the settlement and license agreement, Neos has granted Teva the right to manufacture and market its generic version of Cotempla XR-ODT extended-release orally disintegrating tablets in the ...

Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist.

The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR ...